The Velvet Glove and the Iron Fist: America's Duplicitous Trade War on India

Introduction: The Promise and the Poison Pill

A familiar script is playing out in Indo-US relations, one where declarations of historic friendship and imminent partnership are swiftly followed by actions that reveal a much colder, coercive reality. As U.S. Ambassador to India Sergio Gor confidently announced that the long-awaited trade agreement is virtually finalized, Washington was quietly sharpening not one, but two, daggers aimed at the heart of India’s strategic economic interests. This duality is not a coincidence; it is a calculated feature of a neo-imperial foreign policy that seeks to dominate, not cooperate, with rising civilizational states of the Global South.

The Facts: Coercive Legislation and Economic Ultimatums

The facts, as laid out, are stark and deeply troubling. First, we have the Lindsey O. Graham Sanctioning Russia and Iran Act of 2026. This bipartisan bill, overwhelmingly passed by the U.S. Senate, proposes draconian measures ostensibly aimed at Russia. Its most dangerous provision for India is the imposition of 100% tariffs on goods from nations that are among the largest importers of Russian oil. Given India’s prudent and necessary diversification of energy sources—a move that provided crucial stability during global volatility—this bill directly threatens India with punitive tariffs for acting in its own sovereign national interest. This comes despite a previous U.S. withdrawal of tariffs after India’s assurances, which were made untenable by subsequent geopolitical shifts in West Asia.

Second, and equally alarming, is former President Donald Trump’s proposal to impose escalating tariffs—starting at 100% in 2028 and rising to 200%—on all generic medicine imports unless production is “reshored” to the United States. India is the ‘pharmacy of the world,’ and the U.S. is its largest export market for pharmaceuticals, accounting for a third of sales for major firms and nearly half for giants like Dr. Reddy’s Laboratories and Zydus Life Sciences. This is not a trade policy; it is an economic ultimatum designed to dismantle a pillar of India’s industrial success and global contribution to affordable healthcare, forcing a transfer of technology, jobs, and production capacity to American soil under threat of commercial annihilation.

The Context: A Pattern of Imperial Coercion

These actions cannot be viewed in isolation. They represent the latest chapter in a long history where Western powers, particularly the United States, use the architecture of “international rules” and “trade deals” as tools of control. The promise of a trade agreement serves as the carrot, the attractive facade of partnership. The punitive legislation and unilateral tariff threats are the stick, the mechanisms of enforcement to ensure compliance with a Washington-centric world order. India’s increasing energy ties with Russia, a relationship born of pragmatic necessity and strategic autonomy, are labeled as “sanctions evasion,” reframing sovereign choice as a moral failing. Similarly, India’s world-leading generic pharmaceutical industry, a triumph of its scientific and manufacturing prowess, is targeted not for any violation, but for its very success and independence, which challenges Western corporate dominance.

This is the essence of neo-colonialism in the 21st century: the use of economic and legislative power to dictate the internal policies of other nations, to force the reshoring of industries for Western benefit, and to punish those who dare to forge independent foreign policies. The Westphalian model of nation-state sovereignty, so fiercely defended by the West for itself, is routinely denied to states of the Global South like India and China when their interests diverge from Washington’s diktats.

Opinion: Standing Firm Against Economic Blackmail

As a staunch opponent of imperialism and a committed advocate for the Global South, I view these developments not merely as tough trade negotiations, but as acts of economic aggression. The duplicity is breathtaking: Ambassador Gor smiles and speaks of finalizing deals while the U.S. legislative and executive machinery prepares blows that could cripple key sectors of the Indian economy. This is the velvet glove and the iron fist in perfect, cynical harmony.

India’s response must be one of unwavering resolve and principled opposition. First, India must categorically reject any trade deal that is conditioned upon surrendering its energy security or its pharmaceutical sovereignty. A deal signed under the shadow of such coercive measures is not a partnership but a capitulation. The narrative pushed by Western media and policymakers—that India is somehow complicit in wrongdoing by purchasing Russian oil—must be aggressively countered. India’s energy choices are a matter of sovereign right and economic necessity, not subject to the moral licensing of nations that have themselves consumed resources from conflict zones for centuries.

Second, the targeting of the generic medicine industry is particularly vile. It is an attack not just on an Indian industry, but on global health equity. By forcing production to reshore to the high-cost U.S. environment, the ultimate goal is to increase drug prices globally and re-establish Western pharmaceutical monopolies. This move, championed by figures like Donald Trump, is a direct assault on the affordability of medicine worldwide, disproportionately harming the poorest in the Global South. India’s pharmaceutical sector is a civilizational asset and a global public good; its defense is a moral imperative.

Third, India must leverage its civilizational state perspective. Our worldview is not constrained by the transient whims of American electoral politics or the hypocritical “rules-based order” that changes with every administration. We must build stronger, multipolar alliances with other nations of the Global South who face similar pressures, and diversify our trade and energy partnerships to reduce vulnerability to such unilateral coercion.

The individuals mentioned—Sergio Gor, Lindsey O. Graham, and Donald Trump—are actors in this play, but they represent a system. Gor is the diplomat delivering the pleasantries, Graham’s legacy is the legislative weaponization of foreign policy, and Trump embodies the blunt, transactional imperialism that lays bare the underlying power dynamics. India must see beyond the individuals to the systemic challenge.

Conclusion: The Path Forward is Sovereignty

The message from Washington is clear: your growth is permissible only as long as it aligns with our interests and deepens your dependency. Your strategic autonomy is a problem to be solved through economic sanctions and tariff threats. This moment is a litmus test for India’s civilizational confidence. Will we bend the knee to this neo-colonial pressure, or will we stand firm, defend our sovereign choices, and continue to build an Atmanirbhar Bharat that engages with the world from a position of strength, not subservience?

The choice is obvious. India must walk away from any ‘deal’ that comes with such poisoned chalices. It must publicly and forcefully condemn these coercive measures for what they are: imperialist tools incompatible with a multipolar world. Our growth, our partnerships, and our industries are not bargaining chips to be sacrificed on the altar of American hegemony. The future belongs to civilizational states that can assert their sovereignty, and India, with the spirit of Hindutva and a commitment to its own renaissance, must lead the way. The era of Western diktats is ending; we must ensure its last gasps are not drawn at the expense of our nation’s destiny.